Evotec SE (EVO)
4.672
+0.15
(+3.37%)
USD |
NASDAQ |
May 31, 16:00
4.685
+0.01
(+0.27%)
After-Hours: 20:00
Evotec Revenue (Quarterly): 226.72M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 226.72M |
| December 31, 2023 | 216.80M |
| September 30, 2023 | 213.70M |
| June 30, 2023 | 185.68M |
| March 31, 2023 | 229.37M |
| December 31, 2022 | 246.11M |
| September 30, 2022 | 175.17M |
| June 30, 2022 | 183.43M |
| March 31, 2022 | 184.78M |
| December 31, 2021 | 213.95M |
| September 30, 2021 | 188.25M |
| June 30, 2021 | 166.58M |
| March 31, 2021 | 160.37M |
| December 31, 2020 | 167.53M |
| September 30, 2020 | 151.35M |
| June 30, 2020 | 122.89M |
| March 31, 2020 | 131.77M |
| December 31, 2019 | 138.50M |
| September 30, 2019 | 127.06M |
| June 30, 2019 | 115.98M |
| March 31, 2019 | 117.97M |
| December 31, 2018 | 111.03M |
| September 30, 2018 | 115.36M |
| June 30, 2018 | 116.10M |
| March 31, 2018 | 100.29M |
| Date | Value |
|---|---|
| December 31, 2017 | 108.60M |
| September 30, 2017 | 79.01M |
| June 30, 2017 | 58.78M |
| March 31, 2017 | 54.23M |
| December 31, 2016 | 47.34M |
| September 30, 2016 | 50.42M |
| June 30, 2016 | 42.90M |
| March 31, 2016 | 41.35M |
| December 31, 2015 | 43.19M |
| September 30, 2015 | 36.94M |
| June 30, 2015 | 36.93M |
| March 31, 2015 | 24.31M |
| December 31, 2014 | 38.17M |
| September 30, 2014 | 24.98M |
| June 30, 2014 | 30.82M |
| March 31, 2014 | 24.13M |
| December 31, 2013 | 34.87M |
| September 30, 2013 | 31.32M |
| June 30, 2013 | 25.63M |
| March 31, 2013 | 22.53M |
| December 31, 2012 | 29.92M |
| September 30, 2012 | 27.70M |
| June 30, 2012 | 28.17M |
| March 31, 2012 | 26.37M |
| December 31, 2011 | 27.51M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
115.98M
Minimum
Jun 2019
246.11M
Maximum
Dec 2022
177.30M
Average
179.30M
Median
Revenue (Quarterly) Benchmarks
| Centogene NV | -- |
| Affimed NV | 0.4448M |
| InflaRx NV | 0.0391M |
| MorphoSys AG | 63.62M |
| BioNTech SE | 203.77M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.45M |
| Total Expenses (Quarterly) | 246.49M |
| EPS Diluted (Quarterly) | -0.0652 |
| Enterprise Value | 1.773B |
| Gross Profit Margin (Quarterly) | 16.65% |
| Profit Margin (Quarterly) | -9.90% |
| Earnings Yield | -5.93% |
| Normalized Earnings Yield | -5.062 |